United States & Moderna
14 shared events · Importance 6 · Last updated Jun 11, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Accidents
United States: United States>>> has bolstered precautions, including screening air passengers and suspending visa services, and has provided $13 million in assistance for the response.
Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
International
United States: The United States>>> has announced additional aid to the Democratic Republic of the Congo>>> for the Ebola response and has implemented temporary travel bans for non-citizens from affected countries. It also plans to establish a quarantine facility in Kenya>>> for exposed Americans.
Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.
May 21, 2026 · 627 articles
Business
United States: The United States is the host country for these unicorn companies, benefiting significantly from immigrant entrepreneurship in its technology and startup sectors.
Moderna: Moderna is an immigrant-founded unicorn company that has gone public since 2016.
Jun 04, 2026 · 6 articles
Accidents
United States: The United States>>> has pledged financial aid and is monitoring the Ebola outbreak, with some of its citizens exposed or infected, but its previous aid cuts and withdrawal from the World Health Organization>>> have been criticized for weakening global health response capacity.
Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.
May 18, 2026 · 505 articles
Tech
United States: United States>>> is one of the countries where patients were enrolled for the KEYNOTE-942 trial, contributing to the global scope of the research. Its involvement highlights its participation in international medical studies and its significant burden of skin cancer cases.
Moderna: As the manufacturer of intismeran, Moderna>>> is a key beneficiary of the positive clinical trial results, which could lead to increased revenue and market share in cancer treatment. The success of intismeran validates Moderna>>>'s mRNA vaccine platform for oncology applications.
Jun 01, 2026 · 6 articles
Regulatory
Moderna: Moderna, a manufacturer of widely used COVID-19 vaccines, did not immediately comment on the new policy.
May 20, 2025 · 12 articles
Regulatory
Moderna: Moderna had $766 million in funding for its mRNA-1018 vaccine canceled by the United States — United States Department of Health and Human Services, adding uncertainty to the vaccine's development.
May 29, 2025 · 6 articles
NEWSDESK
Explore this relationship live
Track how United States and Moderna interact across events, view sentiment trends, and discover connected entities.
Open Dashboard